Jaar Eduhealth Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 01-07-2024
- Paid Up Capital ₹ 0.10 M
as on 01-07-2024
- Company Age 5 Year, 11 Months
- Last Filing with ROC 31 Mar 2021
- Revenue 584.41%
(FY 2021)
- Profit 99.55%
(FY 2021)
- Ebitda 112.65%
(FY 2021)
- Net Worth -0.49%
(FY 2021)
- Total Assets 7.03%
(FY 2021)
About Jaar Eduhealth
The Company is engaged in the Education Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Shakti Padhiary and Smruti Bal serve as directors at the Company.
- CIN/LLPIN
U80900OR2019PTC030194
- Company No.
030194
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Jan 2019
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Cuttack
Industry
Company Details
- Location
Bhubaneswar, Orissa, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Jaar Eduhealth?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shakti Padhiary  | Director | 19-Jun-2020 | Current |
| Smruti Bal | Director | 01-Jan-2020 | Current |
Financial Performance and Corporate Structure Insights of Jaar Eduhealth.
Jaar Eduhealth Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 584.41% increase. The company also saw a substantial improvement in profitability, with a 99.55% increase in profit. The company's net worth dipped by a decrease of 0.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jaar Eduhealth?
In 2021, Jaar Eduhealth had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ingenuity And Innovation Global Edutech Private LimitedActive 4 years 5 monthsSmruti Bal is a mutual person
Ingenuity And Innovation Global Biotech Private LimitedActive 2 years 4 monthsSmruti Bal is a mutual person
- Ingenuity And Innovation Global Technology Private LimitedActive 4 years 5 months
Smruti Bal is a mutual person
- Ingenuity And Innovation Global Eduhealth Private LimitedActive 4 years 5 months
Smruti Bal is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Jaar Eduhealth?
Unlock and access historical data on people associated with Jaar Eduhealth, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jaar Eduhealth, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jaar Eduhealth's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
